Asset Management
Compare Stocks
5 / 10Stock Comparison
CWD vs JCAP vs ARES vs PRAA vs ECPG
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Credit Services
Asset Management
Financial - Credit Services
Financial - Mortgages
CWD vs JCAP vs ARES vs PRAA vs ECPG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Asset Management | Financial - Credit Services | Asset Management | Financial - Credit Services | Financial - Mortgages |
| Market Cap | $21M | $1.19B | $40.44B | $803M | $1.76B |
| Revenue (TTM) | $51M | $433M | $6.47B | $1.24B | $1.76B |
| Net Income (TTM) | $-21M | $140M | $527M | $-305M | $296M |
| Gross Margin | 48.2% | 71.2% | 74.8% | 99.2% | 69.0% |
| Operating Margin | -26.0% | 50.8% | 27.2% | 33.9% | 35.4% |
| Forward P/E | — | 7.2x | 20.2x | 25.9x | 6.9x |
| Total Debt | $82M | $1.19B | $14.91B | $32M | $4.13B |
| Cash & Equiv. | $2M | $36M | $1.50B | $104M | $157M |
CWD vs JCAP vs ARES vs PRAA vs ECPG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 25 | May 26 | Return |
|---|---|---|---|
| CaliberCos Inc. (CWD) | 100 | 27.2 | -72.8% |
| Jefferson Capital, … (JCAP) | 100 | 110.6 | +10.6% |
| Ares Management Cor… (ARES) | 100 | 71.1 | -28.9% |
| PRA Group, Inc. (PRAA) | 100 | 141.6 | +41.6% |
| Encore Capital Grou… (ECPG) | 100 | 212.4 | +112.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CWD vs JCAP vs ARES vs PRAA vs ECPG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CWD lags the leaders in this set but could rank higher in a more targeted comparison.
JCAP is the #2 pick in this set and the best alternative if quality and efficiency is your priority.
- Efficiency ratio 0.2% vs CWD's 0.7% (lower = leaner)
- Efficiency ratio 0.2% vs CWD's 0.7%
ARES ranks third and is worth considering specifically for income & stability and growth exposure.
- Dividend streak 7 yrs, beta 1.62, yield 6.6%
- Rev growth 66.6%, EPS growth -5.3%
- 9.3% 10Y total return vs ECPG's 214.3%
- Beta 1.62, yield 6.6%, current ratio 2.24x
Among these 5 stocks, PRAA doesn't own a clear edge in any measured category.
ECPG carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and valuation efficiency.
- Lower volatility, beta 1.07, current ratio 595.09x
- PEG 0.67 vs ARES's 1.15
- Lower P/E (6.9x vs 20.2x), PEG 0.67 vs 1.15
- Beta 1.07 vs CWD's 1.84, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 66.6% NII/revenue growth vs CWD's -43.8% | |
| Value | Lower P/E (6.9x vs 20.2x), PEG 0.67 vs 1.15 | |
| Quality / Margins | Efficiency ratio 0.2% vs CWD's 0.7% (lower = leaner) | |
| Stability / Safety | Beta 1.07 vs CWD's 1.84, lower leverage | |
| Dividends | 6.6% yield, 7-year raise streak, vs JCAP's 3.0%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +149.8% vs CWD's -79.8% | |
| Efficiency (ROA) | Efficiency ratio 0.2% vs CWD's 0.7% |
CWD vs JCAP vs ARES vs PRAA vs ECPG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CWD vs JCAP vs ARES vs PRAA vs ECPG — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
JCAP leads in 2 of 6 categories
PRAA leads 1 • ECPG leads 1 • ARES leads 1 • CWD leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
JCAP leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
ARES is the larger business by revenue, generating $6.5B annually — 126.6x CWD's $51M. JCAP is the more profitable business, keeping 24.3% of every revenue dollar as net income compared to CWD's -38.7%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $51M | $433M | $6.5B | $1.2B | $1.8B |
| EBITDAEarnings before interest/tax | -$7M | $137M | $1.8B | $431M | $710M |
| Net IncomeAfter-tax profit | -$21M | $140M | $527M | -$305M | $296M |
| Free Cash FlowCash after capex | -$7M | $265M | $1.5B | -$90M | $166M |
| Gross MarginGross profit ÷ Revenue | +48.2% | +71.2% | +74.8% | +99.2% | +69.0% |
| Operating MarginEBIT ÷ Revenue | -26.0% | +50.8% | +27.2% | +33.9% | +35.4% |
| Net MarginNet income ÷ Revenue | -38.7% | +24.3% | +8.2% | -24.6% | +14.6% |
| FCF MarginFCF ÷ Revenue | +1.1% | +37.4% | +23.9% | -7.3% | +7.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | — | — | -80.9% | +2.1% | +100.0% |
Valuation Metrics
PRAA leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 7.5x trailing earnings, ECPG trades at a 88% valuation discount to ARES's 62.8x P/E. Adjusting for growth (PEG ratio), ECPG offers better value at 0.73x vs ARES's 3.56x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $21M | $1.2B | $40.4B | $803M | $1.8B |
| Enterprise ValueMkt cap + debt − cash | $101M | $2.3B | $53.9B | $731M | $5.7B |
| Trailing P/EPrice ÷ TTM EPS | -1.07x | 11.27x | 62.83x | -2.68x | 7.54x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 7.20x | 20.23x | 25.94x | 6.86x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 3.56x | — | 0.73x |
| EV / EBITDAEnterprise value multiple | — | 10.34x | 26.88x | 1.69x | 8.79x |
| Price / SalesMarket cap ÷ Revenue | 0.41x | 2.74x | 6.25x | 0.65x | 1.00x |
| Price / BookPrice ÷ Book value/share | 1.88x | 3.11x | 3.08x | 0.79x | 1.98x |
| Price / FCFMarket cap ÷ FCF | 38.04x | 7.34x | 26.19x | — | 13.87x |
Profitability & Efficiency
JCAP leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
JCAP delivers a 34.9% return on equity — every $100 of shareholder capital generates $35 in annual profit, vs $-2 for CWD. PRAA carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to CWD's 7.27x. On the Piotroski fundamental quality scale (0–9), ARES scores 8/9 vs JCAP's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -2.3% | +34.9% | +6.2% | -26.0% | +30.7% |
| ROA (TTM)Return on assets | -25.3% | +8.1% | +1.9% | -5.9% | +5.6% |
| ROICReturn on invested capital | -5.4% | +12.6% | +6.1% | +11.2% | +9.8% |
| ROCEReturn on capital employed | -7.2% | +16.6% | +7.3% | +8.7% | +12.6% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 4 | 8 | 5 | 7 |
| Debt / EquityFinancial leverage | 7.27x | 3.12x | 1.71x | 0.03x | 4.23x |
| Net DebtTotal debt minus cash | $79M | $1.2B | $13.4B | -$72M | $4.0B |
| Cash & Equiv.Liquid assets | $2M | $36M | $1.5B | $104M | $157M |
| Total DebtShort + long-term debt | $82M | $1.2B | $14.9B | $32M | $4.1B |
| Interest CoverageEBIT ÷ Interest expense | -1.64x | 0.00x | 2.68x | 0.06x | 3.45x |
Total Returns (Dividends Reinvested)
ECPG leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ARES five years ago would be worth $26,021 today (with dividends reinvested), compared to $62 for CWD. Over the past 12 months, ECPG leads with a +149.8% total return vs CWD's -79.8%. The 3-year compound annual growth rate (CAGR) favors ECPG at 20.1% vs CWD's -81.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -30.9% | -6.6% | -25.1% | +19.5% | +47.1% |
| 1-Year ReturnPast 12 months | -79.8% | +13.9% | -21.1% | +57.2% | +149.8% |
| 3-Year ReturnCumulative with dividends | -99.4% | +13.9% | +64.7% | -39.3% | +73.1% |
| 5-Year ReturnCumulative with dividends | -99.4% | +13.9% | +160.2% | -46.8% | +90.8% |
| 10-Year ReturnCumulative with dividends | -99.4% | +13.9% | +929.6% | -32.2% | +214.3% |
| CAGR (3Y)Annualised 3-year return | -81.6% | +4.4% | +18.1% | -15.3% | +20.1% |
Risk & Volatility
Evenly matched — PRAA and ECPG each lead in 1 of 2 comparable metrics.
Risk & Volatility
ECPG is the less volatile stock with a 1.07 beta — it tends to amplify market swings less than CWD's 1.84 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PRAA currently trades 92.6% from its 52-week high vs CWD's 2.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.84x | 1.21x | 1.62x | 1.82x | 1.07x |
| 52-Week HighHighest price in past year | $48.00 | $23.80 | $195.26 | $22.55 | $92.64 |
| 52-Week LowLowest price in past year | $0.87 | $15.98 | $95.80 | $10.25 | $32.66 |
| % of 52W HighCurrent price vs 52-week peak | +2.0% | +85.7% | +63.1% | +92.6% | +88.8% |
| RSI (14)Momentum oscillator 0–100 | 42.0 | 49.5 | 63.2 | 61.2 | 70.6 |
| Avg Volume (50D)Average daily shares traded | 153K | 300K | 3.7M | 449K | 327K |
Analyst Outlook
ARES leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: JCAP as "Buy", ARES as "Buy", PRAA as "Hold", ECPG as "Buy". Consensus price targets imply 44.0% upside for ARES (target: $177) vs 3.4% for ECPG (target: $85). For income investors, ARES offers the higher dividend yield at 6.56% vs JCAP's 3.03%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | — | $27.00 | $177.38 | $26.00 | $85.00 |
| # AnalystsCovering analysts | — | 9 | 22 | 13 | 15 |
| Dividend YieldAnnual dividend ÷ price | — | +3.0% | +6.6% | — | — |
| Dividend StreakConsecutive years of raises | 0 | 1 | 7 | 2 | 2 |
| Dividend / ShareAnnual DPS | — | $0.62 | $8.08 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | +2.5% | +5.1% |
JCAP leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). PRAA leads in 1 (Valuation Metrics). 1 tied.
CWD vs JCAP vs ARES vs PRAA vs ECPG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CWD or JCAP or ARES or PRAA or ECPG a better buy right now?
For growth investors, Ares Management Corporation (ARES) is the stronger pick with 66.
6% revenue growth year-over-year, versus -43. 8% for CaliberCos Inc. (CWD). Encore Capital Group, Inc. (ECPG) offers the better valuation at 7. 5x trailing P/E (6. 9x forward), making it the more compelling value choice. Analysts rate Jefferson Capital, Inc. Common Stock (JCAP) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CWD or JCAP or ARES or PRAA or ECPG?
On trailing P/E, Encore Capital Group, Inc.
(ECPG) is the cheapest at 7. 5x versus Ares Management Corporation at 62. 8x. On forward P/E, Encore Capital Group, Inc. is actually cheaper at 6. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Encore Capital Group, Inc. wins at 0. 67x versus Ares Management Corporation's 1. 15x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CWD or JCAP or ARES or PRAA or ECPG?
Over the past 5 years, Ares Management Corporation (ARES) delivered a total return of +160.
2%, compared to -99. 4% for CaliberCos Inc. (CWD). Over 10 years, the gap is even starker: ARES returned +929. 6% versus CWD's -99. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CWD or JCAP or ARES or PRAA or ECPG?
By beta (market sensitivity over 5 years), Encore Capital Group, Inc.
(ECPG) is the lower-risk stock at 1. 07β versus CaliberCos Inc. 's 1. 84β — meaning CWD is approximately 72% more volatile than ECPG relative to the S&P 500. On balance sheet safety, PRA Group, Inc. (PRAA) carries a lower debt/equity ratio of 3% versus 7% for CaliberCos Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CWD or JCAP or ARES or PRAA or ECPG?
By revenue growth (latest reported year), Ares Management Corporation (ARES) is pulling ahead at 66.
6% versus -43. 8% for CaliberCos Inc. (CWD). On earnings-per-share growth, the picture is similar: Encore Capital Group, Inc. grew EPS 287. 1% year-over-year, compared to -535. 2% for PRA Group, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CWD or JCAP or ARES or PRAA or ECPG?
Jefferson Capital, Inc.
Common Stock (JCAP) is the more profitable company, earning 24. 3% net margin versus -38. 7% for CaliberCos Inc. — meaning it keeps 24. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JCAP leads at 50. 8% versus -26. 0% for CWD. At the gross margin level — before operating expenses — PRAA leads at 99. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CWD or JCAP or ARES or PRAA or ECPG more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Encore Capital Group, Inc. (ECPG) is the more undervalued stock at a PEG of 0. 67x versus Ares Management Corporation's 1. 15x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Encore Capital Group, Inc. (ECPG) trades at 6. 9x forward P/E versus 25. 9x for PRA Group, Inc. — 19. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ARES: 44. 0% to $177. 38.
08Which pays a better dividend — CWD or JCAP or ARES or PRAA or ECPG?
In this comparison, ARES (6.
6% yield), JCAP (3. 0% yield) pay a dividend. CWD, PRAA, ECPG do not pay a meaningful dividend and should not be held primarily for income.
09Is CWD or JCAP or ARES or PRAA or ECPG better for a retirement portfolio?
For long-horizon retirement investors, Ares Management Corporation (ARES) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (6.
6% yield, +929. 6% 10Y return). CaliberCos Inc. (CWD) carries a higher beta of 1. 84 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ARES: +929. 6%, CWD: -99. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CWD and JCAP and ARES and PRAA and ECPG?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CWD is a small-cap quality compounder stock; JCAP is a small-cap high-growth stock; ARES is a mid-cap high-growth stock; PRAA is a small-cap quality compounder stock; ECPG is a small-cap high-growth stock. JCAP, ARES pay a dividend while CWD, PRAA, ECPG do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.